
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+11
Poised to Deliver Breakthroughs in Oncology and CNS Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS. The companys lead compound, BXQ-350, is a novel S1P modulator. With our highly experienced biotech leadership team and expertise in Oncology, we are urgently progressing our pipeline to develop life-changing oncology therapies on our path to becoming a leading biotech/pharmaceutical company. To learn more about Bexion Pharmaceuticals, please visit Bexionpharma.com or call (859) 446-7386
Oncology,neuropathy,innovation,quality,manufacturing,research & development,great place to work,leadership,service,integrity,commitment,passion,transformative therapy,biopharmaceutical,biotechnology,and novel s1p modulator
Bexion pharmaceuticals operates in the Biotechnology industry.
Bexion pharmaceuticals's revenue is 11m - 100m
Bexion pharmaceuticals has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.